v3.26.1
Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Revenue $ 7,670 $ 19,223 $ 14,143 $ 33,968
Significant segment expenses        
Loss from operations 134,968 176,227 263,472 367,595
Other non-operating income (loss), net 3,962 4,330 10,359 (6,947)
Income tax benefit 1 0 4,604 158
Total segment loss 131,005 171,897 248,509 374,384
Reportable Segment        
Segment Reporting [Line Items]        
Revenue 7,670 19,223 14,143 33,968
Significant segment expenses        
Salaries 67,170 83,037 141,468 166,591
Consumables 14,960 29,121 22,106 83,798
Platform 6,679 13,792 14,293 22,557
Discovery 4,044 15,380 10,377 21,667
Clinical development 10,673 11,960 17,242 22,524
Depreciation and amortization 18,167 26,185 37,840 45,516
Other segment items 20,945 15,975 34,289 38,910
Loss from operations 134,968 176,227 263,472 367,595
Other non-operating income (loss), net 3,962 4,330 10,359 (6,947)
Income tax benefit 1 0 4,604 158
Total segment loss 131,005 171,897 248,509 374,384
Supplemental asset information        
Total expenditures for additions to long-lived assets $ 43 $ 2,266 $ 302 $ 5,244